首页|通窍耳聋丸用于治疗急性中耳炎的疗效观察

通窍耳聋丸用于治疗急性中耳炎的疗效观察

扫码查看
目的 观察通窍耳聋丸用于治疗急性中耳炎的疗效及安全性.方法 选取急性中耳炎患者 120 例,按随机数字表法将患者分为观察组和对照组,每组 60 例.对照组采取纯西医治疗方法,口服阿莫西林克拉维酸钾,并以左氧氟沙星合地塞米松耳浴.观察组在对照组基础上加服通窍耳聋丸.比较两组患者疗效,治疗前后症状评分及血清炎性因子[血清白细胞介素-2(IL-2)、白细胞介素-4(IL-4)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、降钙素原(PCT)、血小板活化因子(PAF)]水平,不良反应发生情况.结果 观察组总有效率为 96.67%,高于对照组的 85.00%,组间比较有显著差异(P<0.05).治疗后,两组耳聋(听力下降)、耳鸣、耳痛、耳闷、鼓膜充血、鼓室积液评分较治疗前均显著下降,且观察组耳聋(听力下降)、耳鸣、耳痛、耳闷、鼓膜充血、鼓室积液评分分别为(0.51±0.27)、(0.09±0.03)、(0.19±0.05)、(0.10±0.03)、(0.28±0.07)、(0.36±0.09)分,低于对照组的(0.77±0.22)、(0.12±0.06)、(0.27±0.14)、(0.12±0.06)、(0.35±0.09)、(0.56±0.07)分,组间比较有显著差异(P<0.05).治疗后,两组IL-2、IL-4、IL-6、TNF-α、PCT、PAF水平均显著下降,且观察组IL-2、IL-4、IL-6、TNF-α、PCT、PAF分别为(3.02±0.17)ng/L、(3.52±0.45)ng/L、(2.32±0.28)ng/L、(23.88±3.02)pg/ml、(1.84±0.31)ng/ml、(100.21±13.96)μg/L,低于对照组的(3.99±0.32)ng/L、(4.73±0.56)ng/L、(3.13±0.19)ng/L、(55.31±5.33)pg/ml、(3.33±0.55)ng/ml、(131.62±15.23)μg/L,组间比较有显著差异(P<0.05).两组不良反应发生率比较无差异(χ2=2.034,P=0.154>0.05).结论 通窍耳聋丸联合常规西医疗法用于急性中耳炎的治疗具有较好的有效性和安全性,值得临床推广.
Observation on the curative effect of Tongqiao Erlong pill in the treatment of acute otitis media
Objective To observe the curative effect and safety of Tongqiao Erlong pill in the treatment of acute otitis media.Methods A total of 120 patients with acute otitis media were selected and divided into an observation group and a control group according to random number table method,with 60 cases in each group.The control group was treated with Western medicine,including oral amoxicillin and clavulanate potassium,and levofloxacin combined with dexamethasone ear bath.The observation group was given Tongqiao Erlong pill on the basis of the control group.Patients in both groups were compared in terms of efficacy,symptom score,serum inflammatory factors[interleukin-2(IL-2),interleukin-4(IL-4),interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),procalcitonin(PCT),platelet activating factor(PAF)]before and after treatment,and the occurrence of adverse reactions.Results The total effective rate of the observation group was 96.67%,which was higher than 85.00%of the control group,and there was significant difference between groups(P<0.05).After treatment,the scores of deafness(hearing loss),tinnitus,earache,aural fullness,tympanic congestion and tympanic effusion in both groups were significantly decreased compared with those before treatment;the scores of deafness(hearing loss),tinnitus,earache,aural fullness,tympanic congestion and tympanic effusion in the observation group were(0.51±0.27),(0.09±0.03),(0.19±0.05),(0.10±0.03),(0.28±0.07)and(0.36±0.09)points,which were lower than(0.77±0.22),(0.12±0.06),(0.27±0.14),(0.12±0.06),(0.35±0.09)and(0.56±0.07)points in the control group;there was significant difference between groups(P<0.05).After treatment,the levels of IL-2,IL-4,IL-6,TNF-α,PCT and PAF were significantly decreased in both groups;in the observation group,IL-2,IL-4,IL-6,TNF-α,PCT and PAF were(3.02±0.17)ng/L,(3.52±0.45)ng/L,(2.32±0.28)ng/L,(23.88±3.02)pg/ml,(1.84±0.31)ng/ml and(100.21±13.96)μg/L,which were lower than(3.99±0.32)ng/L,(4.73±0.56)ng/L,(3.13±0.19)ng/L,(55.31±5.33)pg/ml,(3.33±0.55)ng/ml and(131.62±15.23)μg/L in the control group;there was significant difference between groups(P<0.05).There was no difference in the incidence of adverse reactions between the two groups(χ2=2.034,P=0.154>0.05).Conclusion Tongqiao Erlong pill combined with conventional western medicine has good efficacy and safety in the treatment of acute otitis media,and is worthy of clinical promotion.

Acute otitis mediaDeafnessTinnitusEaracheAural fullnessTongqiao Erlong pill

张恩琴

展开 >

725000 安康市中医医院

急性中耳炎 耳聋 耳鸣 耳痛 耳闷 通窍耳聋丸

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(13)